These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18175394)

  • 1. The pathogenesis of cell death in Parkinson's disease--2007.
    Olanow CW
    Mov Disord; 2007 Sep; 22 Suppl 17():S335-42. PubMed ID: 18175394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.
    Giordana MT; D'Agostino C; Albani G; Mauro A; Di Fonzo A; Antonini A; Bonifati V
    Mov Disord; 2007 Jan; 22(2):275-8. PubMed ID: 17149743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease.
    McNaught KS; Olanow CW
    Neurobiol Aging; 2006 Apr; 27(4):530-45. PubMed ID: 16207501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
    McNaught KS; Olanow CW
    Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of Parkinson's disease.
    Gandhi S; Wood NW
    Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic mutations in Parkinson disease.
    Tan EK; Skipper LM
    Hum Mutat; 2007 Jul; 28(7):641-53. PubMed ID: 17385668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on the genetics of Parkinson's disease.
    Gasser T
    Mov Disord; 2007 Sep; 22 Suppl 17():S343-50. PubMed ID: 18175395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease.
    Thomas B; Beal MF
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R183-94. PubMed ID: 17911161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic mechanisms of neurodegeneration in Parkinson disease.
    Mullin S; Schapira AH
    Neurol Clin; 2015 Feb; 33(1):1-17. PubMed ID: 25432720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia.
    Kim T; Vemuganti R
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):1910-1926. PubMed ID: 28273718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of sporadic Parkinson's disease: contribution of genetic and environmental risk factors].
    Takahashi R; Kawamata J; Takeuchi H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):885-7. PubMed ID: 20030238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of Parkinson's disease: implications from familial Parkinson's disease].
    Iwatsubo T; Ito G; Takatori S; Hannno Y; Kuwahara T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):899-901. PubMed ID: 16447757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease.
    Ahlskog JE
    Mov Disord; 2005 Mar; 20(3):271-82. PubMed ID: 15580550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
    Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mitochondrial dysfunction and oxidative damages in the molecular pathology of Parkinson's disease].
    Shadrina MI; Slominskiĭ PA
    Mol Biol (Mosk); 2008; 42(5):809-19. PubMed ID: 18988530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects of genetic contributions to Parkinson's disease.
    Hofer A; Gasser T
    J Mol Neurosci; 2004; 24(3):417-24. PubMed ID: 15655263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.